Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Lineage Cell Therapeutics, Inc. (LCTX)
Price—Loading quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.6M | $9.5M | $8.9M | $14.7M | $4.3M | $1.8M | $3.5M | $5.0M | $3.5M | $5.9M | $7.0M | $5.2M | $4.4M | $3.9M | $4.4M | $3.7M | $1.9M |
| Gross profit | $14.4M | $9.2M | $8.3M | $14.0M | $2.9M | $1.4M | $3.1M | $4.7M | $3.3M | $5.6M | $5.9M | $4.4M | $3.6M | $3.5M | $4.4M | $3.7M | — |
| Gross margin | 99.00% | 96.48% | 92.50% | 95.05% | 67.15% | 78.92% | 88.28% | 93.95% | 95.14% | 93.96% | 84.27% | 84.04% | 82.12% | 88.91% | 98.21% | 99.25% | — |
| Research & development | $17.7M | $12.5M | $15.7M | $14.0M | $33.9M | $12.3M | $17.9M | $21.0M | $24.0M | $36.1M | $42.6M | $37.5M | $26.6M | $18.1M | $13.7M | $8.2M | $3.2M |
| Operating expenses | $51.2M | $31.0M | $33.7M | $36.5M | $52.1M | $27.9M | $42.0M | $46.5M | $43.9M | $64.5M | $71.7M | $55.1M | $59.6M | $28.5M | $23.0M | $13.5M | $5.4M |
| Operating income | −$36.6M | −$21.5M | −$24.7M | −$22.5M | −$49.2M | −$26.4M | −$38.9M | −$41.8M | −$38.9M | −$59.0M | −$65.8M | −$50.7M | −$56.0M | −$25.0M | −$18.7M | −$9.9M | −$3.5M |
| Operating margin | −251.57% | −226.11% | −276.50% | −153.17% | −1,133.63% | −1,448.36% | −1,106.00% | −837.91% | −1,124.99% | −995.56% | −935.32% | −966.48% | −1,262.65% | −638.53% | −421.42% | −265.70% | −182.86% |
| EBITDA | −$35.9M | −$20.9M | −$24.2M | −$21.9M | −$48.5M | −$25.6M | −$37.9M | −$40.7M | −$38.0M | −$57.8M | −$64.7M | −$49.6M | −$52.0M | −$22.2M | −$16.3M | −$8.9M | −$3.5M |
| EBITDA margin | −246.77% | −219.93% | −270.22% | −149.21% | −1,118.36% | −1,403.29% | −1,077.50% | −816.24% | −1,097.60% | −975.64% | −920.00% | −946.43% | −1,173.50% | −566.17% | −368.09% | −240.65% | −181.06% |
| Net income | −$63.5M | −$18.6M | −$21.5M | −$26.3M | −$43.0M | −$20.6M | −$11.7M | −$46.0M | −$20.0M | $33.6M | −$47.0M | −$36.4M | −$43.9M | −$21.4M | −$16.5M | −$11.2M | −$5.1M |
| Net profit margin | −436.47% | −195.90% | −240.20% | −178.69% | −990.99% | −1,130.83% | −333.12% | −922.01% | −577.67% | 566.81% | −667.87% | −694.36% | −989.69% | −547.23% | −372.46% | −301.63% | −267.22% |
| Basic EPSper basic share | -$0.28 | -$0.09 | -$0.12 | -$0.15 | -$0.26 | -$0.14 | -$0.08 | -$0.36 | -$0.17 | $0.35 | -$0.59 | -$0.55 | -$0.81 | -$0.44 | -$0.35 | -$0.28 | -$0.18 |
| Diluted EPSper diluted share | -$0.28 | -$0.09 | -$0.12 | -$0.15 | -$0.26 | -$0.14 | -$0.08 | -$0.36 | -$0.17 | $0.34 | -$0.59 | -$0.55 | -$0.81 | -$0.44 | -$0.35 | -$0.28 | -$0.18 |
Owners
Reported shareholders
19.60%of listed shares
BROADWOOD CAPITAL INC49.56M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BROADWOOD CAPITAL INC | 19.60%49.56M shares |
BlackRock, Inc. | 5.21%13.19M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.58%9.05M shares |
Defender Capital, LLC. | 2.61%6.6M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.10%5.3M shares |
RAFFLES ASSOCIATES LP | 2.06%5.2M shares |
FIFTH THIRD BANCORP | 1.82%4.6M shares |
MILLENNIUM MANAGEMENT LLC | 1.19%3.02M shares |
STATE STREET CORP | 0.92%2.31M shares |
VANGUARD FIDUCIARY TRUST CO | 0.66%1.67M shares |
NORTHERN TRUST CORP | 0.66%1.66M shares |
MORGAN STANLEY | 0.58%1.47M shares |
RENAISSANCE TECHNOLOGIES LLC | 0.53%1.34M shares |
MARSHALL WACE, LLP | 0.51%1.28M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.50%1.27M shares |
UBS Group AG | 0.27%687.05K shares |
RED CRANE WEALTH MANAGEMENT, LLC | 0.24%597.26K shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.23%577.44K shares |
BARCLAYS PLC | 0.20%508.67K shares |
Squarepoint Ops LLC | 0.18%444.77K shares |
Percentages use 252.91M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 12, 2026Form 4 | Culley Brian MPresident and CEO | BuyCommon Shares | 15.0K | $1.63 | $24.4K | 255.5K |
| Jan 27, 2025Form 4 | BROADWOOD CAPITAL INC +2TenPercentOwner | BuyCommon Shares · indirect | 0 | $0.00 | $0.00 | 49.56M |
| Jan 27, 2025Form 4 | BROADWOOD CAPITAL INC +2TenPercentOwner | BuyCommon Shares | 7.89M | $0.76 | $6.00M | 49.56M |
| Jan 27, 2025Form 4 | BROADWOOD CAPITAL INC +2TenPercentOwner | BuyCommon Warrant · derivative · indirect | 0 | $0.00 | $0.00 | 7.89M |
| Jan 27, 2025Form 4 | BROADWOOD CAPITAL INC +2TenPercentOwner | BuyCommon Warrant · derivative | 7.89M | $0.00 | $0.00 | 7.89M |